The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
Authors:
C. W. Lees; A. I. Ali; A. I. Thompson; G. T. Ho; R. O. Forsythe; L. Marquez; C. J. Cochrane; S. Aitken; J. Fennell; P. Rogers; A. G. Shand; I. D. Penman; K. R. Palmer; D. C. Wilson; I. D. Arnott; J. Satsangi
Published in the journal:
Čas. Lék. čes. 2009; 148: 184
Category:
Selected Abstract
Zdroje
Aliment Pharmacol Ther 2009; 29(3): 286–297.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Mirizzi syndrome with cholecystoduodenal fistula – a rare complication of cholecyctolithiasis
- Bloodless medicine
- Malignant melanoma: standards and innovation in diagnostics and therapy
- Treatment of marijuana dependence